APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epoprostenol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Epoprostenol Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchEpoprostenol Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Epoprostenol Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Epoprostenol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epoprostenol Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Epoprostenol Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Epoprostenol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Epoprostenol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Epoprostenol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epoprostenol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epoprostenol include Teva Parenteral, Merck, Glaxosmithkline Inc, Bayer AG, SteadyMed, Sandoz Canada Incorporated, Reata Pharmaceuticals, Arena Pharmaceuticals and Actelion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Epoprostenol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Epoprostenol market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epoprostenol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epoprostenol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Epoprostenol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Epoprostenol Market by Company

Teva Parenteral

Merck

Glaxosmithkline Inc

Bayer AG

SteadyMed

Sandoz Canada Incorporated

Reata Pharmaceuticals

Arena Pharmaceuticals

Actelion

Epoprostenol Segment by Type

Oral Epoprostenol

Injection Epoprostenol

Epoprostenol Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Epoprostenol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epoprostenol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epoprostenol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epoprostenol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Epoprostenol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Epoprostenol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Epoprostenol Table 2. Major Company of Injection Epoprostenol Table 3. Global Epoprostenol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Epoprostenol Sales by Type (2021-2026) & (tons) Table 5. Global Epoprostenol Sales Market Share in Volume by Type (2021-2026) Table 6. Global Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 7. Global Epoprostenol Sales Market Share in Value by Type (2021-2026) Table 8. Global Epoprostenol Price by Type (2021-2026) & (US$/ton) Table 9. Global Epoprostenol Sales by Type (2027-2032) & (tons) Table 10. Global Epoprostenol Sales Market Share in Volume by Type (2027-2032) Table 11. Global Epoprostenol Sales by Type (2027-2032) & (US$ Million) Table 12. Global Epoprostenol Sales Market Share in Value by Type (2027-2032) Table 13. Global Epoprostenol Price by Type (2027-2032) & (US$/ton) Table 14. North America Epoprostenol Sales by Type (2021-2026) & (tons) Table 15. North America Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Epoprostenol Sales by Type (2021-2026) & (tons) Table 17. Europe Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Epoprostenol Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Epoprostenol Sales by Type (2021-2026) & (tons) Table 21. Latin America Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Epoprostenol Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Epoprostenol Sales by Type (2021-2026) & (US$ Million) Table 24. Epoprostenol Industry Trends Table 25. Epoprostenol Industry Drivers Table 26. Epoprostenol Industry Opportunities and Challenges Table 27. Epoprostenol Industry Restraints Table 28. Global Epoprostenol Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Epoprostenol Revenue Market Share by Company (2021-2026) Table 30. Global Epoprostenol Sales by Company (2021-2026) & (tons) Table 31. Global Epoprostenol Sales Share by Company (2021-2026) Table 32. Global Epoprostenol Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Epoprostenol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Epoprostenol Major Company Production Sites and Headquarters Table 35. Global Epoprostenol Company, Product Type & Application Table 36. Global Epoprostenol Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Epoprostenol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Epoprostenol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Epoprostenol Sales by Region (2021-2026) & (tons) Table 41. Global Epoprostenol Sales Market Share in Volume by Region (2021-2026) Table 42. Global Epoprostenol Sales by Region (2021-2026) & (US$ Million) Table 43. Global Epoprostenol Sales Market Share in Value by Region (2021-2026) Table 44. Global Epoprostenol Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Epoprostenol Sales by Region (2027-2032) & (tons) Table 46. Global Epoprostenol Sales Market Share in Volume by Region (2027-2032) Table 47. Global Epoprostenol Sales by Region (2027-2032) & (US$ Million) Table 48. Global Epoprostenol Sales Market Share in Value by Region (2027-2032) Table 49. Global Epoprostenol Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Epoprostenol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Epoprostenol Sales by Application (2021-2026) & (tons) Table 52. Global Epoprostenol Sales Market Share in Volume by Application (2021-2026) Table 53. Global Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 54. Global Epoprostenol Sales Market Share in Value by Application (2021-2026) Table 55. Global Epoprostenol Price by Application (2021-2026) & (US$/ton) Table 56. Global Epoprostenol Sales by Application (2027-2032) & (tons) Table 57. Global Epoprostenol Sales Market Share in Volume by Application (2027-2032) Table 58. Global Epoprostenol Sales by Application (2027-2032) & (US$ Million) Table 59. Global Epoprostenol Sales Market Share in Value by Application (2027-2032) Table 60. Global Epoprostenol Price by Application (2027-2032) & (US$/ton) Table 61. North America Epoprostenol Sales by Application (2021-2026) & (tons) Table 62. North America Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Epoprostenol Sales by Application (2021-2026) & (tons) Table 64. Europe Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Epoprostenol Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Epoprostenol Sales by Application (2021-2026) & (tons) Table 68. Latin America Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Epoprostenol Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Epoprostenol Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Parenteral Company Information Table 72. Teva Parenteral Business Overview Table 73. Teva Parenteral Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Teva Parenteral Epoprostenol Product Portfolio Table 75. Teva Parenteral Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Merck Epoprostenol Product Portfolio Table 80. Merck Recent Development Table 81. Glaxosmithkline Inc Company Information Table 82. Glaxosmithkline Inc Business Overview Table 83. Glaxosmithkline Inc Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Glaxosmithkline Inc Epoprostenol Product Portfolio Table 85. Glaxosmithkline Inc Recent Development Table 86. Bayer AG Company Information Table 87. Bayer AG Business Overview Table 88. Bayer AG Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Bayer AG Epoprostenol Product Portfolio Table 90. Bayer AG Recent Development Table 91. SteadyMed Company Information Table 92. SteadyMed Business Overview Table 93. SteadyMed Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. SteadyMed Epoprostenol Product Portfolio Table 95. SteadyMed Recent Development Table 96. Sandoz Canada Incorporated Company Information Table 97. Sandoz Canada Incorporated Business Overview Table 98. Sandoz Canada Incorporated Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Sandoz Canada Incorporated Epoprostenol Product Portfolio Table 100. Sandoz Canada Incorporated Recent Development Table 101. Reata Pharmaceuticals Company Information Table 102. Reata Pharmaceuticals Business Overview Table 103. Reata Pharmaceuticals Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Reata Pharmaceuticals Epoprostenol Product Portfolio Table 105. Reata Pharmaceuticals Recent Development Table 106. Arena Pharmaceuticals Company Information Table 107. Arena Pharmaceuticals Business Overview Table 108. Arena Pharmaceuticals Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. Arena Pharmaceuticals Epoprostenol Product Portfolio Table 110. Arena Pharmaceuticals Recent Development Table 111. Actelion Company Information Table 112. Actelion Business Overview Table 113. Actelion Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 114. Actelion Epoprostenol Product Portfolio Table 115. Actelion Recent Development Table 116. North America Epoprostenol Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 117. North America Epoprostenol Sales by Country (2021-2026) & (tons) Table 118. North America Epoprostenol Sales Market Share by Country (2021-2026) Table 119. North America Epoprostenol Sales Forecast by Country (2027-2032) & (tons) Table 120. North America Epoprostenol Sales Market Share Forecast by Country (2027-2032) Table 121. North America Epoprostenol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Epoprostenol Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Epoprostenol Market Share by Country (2021-2026) Table 124. North America Epoprostenol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Epoprostenol Market Share Forecast by Country (2027-2032) Table 126. Europe Epoprostenol Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 127. Europe Epoprostenol Sales by Country (2021-2026) & (tons) Table 128. Europe Epoprostenol Sales Market Share by Country (2021-2026) Table 129. Europe Epoprostenol Sales Forecast by Country (2027-2032) & (tons) Table 130. Europe Epoprostenol Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Epoprostenol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Epoprostenol Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Epoprostenol Market Share by Country (2021-2026) Table 134. Europe Epoprostenol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Epoprostenol Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Epoprostenol Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Epoprostenol Sales by Country (2021-2026) & (tons) Table 138. Asia-Pacific Epoprostenol Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Epoprostenol Sales Forecast by Country (2027-2032) & (tons) Table 140. Asia-Pacific Epoprostenol Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Epoprostenol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Epoprostenol Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Epoprostenol Market Share by Country (2021-2026) Table 144. Asia-Pacific Epoprostenol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Epoprostenol Market Share Forecast by Country (2027-2032) Table 146. Latin America Epoprostenol Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 147. Latin America Epoprostenol Sales by Country (2021-2026) & (tons) Table 148. Latin America Epoprostenol Sales Market Share by Country (2021-2026) Table 149. Latin America Epoprostenol Sales Forecast by Country (2027-2032) & (tons) Table 150. Latin America Epoprostenol Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Epoprostenol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Epoprostenol Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Epoprostenol Market Share by Country (2021-2026) Table 154. Latin America Epoprostenol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Epoprostenol Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Epoprostenol Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Epoprostenol Sales by Country (2021-2026) & (tons) Table 158. Middle East and Africa Epoprostenol Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Epoprostenol Sales Forecast by Country (2027-2032) & (tons) Table 160. Middle East and Africa Epoprostenol Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Epoprostenol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Epoprostenol Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Epoprostenol Market Share by Country (2021-2026) Table 164. Middle East and Africa Epoprostenol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Epoprostenol Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Epoprostenol Distributors List Table 169. Epoprostenol Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Epoprostenol Image Figure 2. Global Epoprostenol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epoprostenol Market Size (2021-2032) & (US$ Million) Figure 4. Global Epoprostenol Sales (2021-2032) & (tons) Figure 5. Oral Epoprostenol Image Figure 6. Global Oral Epoprostenol Sales YoY Growth (2021-2032) & (tons) Figure 7. Injection Epoprostenol Image Figure 8. Global Injection Epoprostenol Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Epoprostenol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Epoprostenol Market Share by Type 2025 VS 2032 Figure 11. North America Epoprostenol Sales Market Share in Volume by Type in 2025 Figure 12. North America Epoprostenol Sales Market Share in Value by Type in 2025 Figure 13. Europe Epoprostenol Sales Market Share in Volume by Type in 2025 Figure 14. Europe Epoprostenol Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Epoprostenol Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Epoprostenol Sales Market Share in Value by Type in 2025 Figure 17. Latin America Epoprostenol Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Epoprostenol Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Epoprostenol Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Epoprostenol Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Epoprostenol Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (tons) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (tons) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (tons) Figure 29. Global Epoprostenol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Epoprostenol Market Share by Application 2025 VS 2032 Figure 31. North America Epoprostenol Sales Market Share in Volume by Application in 2025 Figure 32. North America Epoprostenol Sales Market Share in Value by Application in 2025 Figure 33. Europe Epoprostenol Sales Market Share in Volume by Application in 2025 Figure 34. Europe Epoprostenol Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Epoprostenol Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Epoprostenol Sales Market Share in Value by Application in 2025 Figure 37. Latin America Epoprostenol Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Epoprostenol Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Epoprostenol Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Epoprostenol Sales Market Share in Value by Application in 2025 Figure 41. North America Epoprostenol Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 42. North America Epoprostenol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Epoprostenol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Epoprostenol Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Epoprostenol Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. Europe Epoprostenol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Epoprostenol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Epoprostenol Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Epoprostenol Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Asia-Pacific Epoprostenol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Epoprostenol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Epoprostenol Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Epoprostenol Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Latin America Epoprostenol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Epoprostenol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Epoprostenol Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Epoprostenol Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Middle East and Africa Epoprostenol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Epoprostenol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Epoprostenol Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Epoprostenol Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Epoprostenol Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Epoprostenol
  • Injection Epoprostenol
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Teva Parenteral
  • Merck
  • Glaxosmithkline Inc
  • Bayer AG
  • SteadyMed
  • Sandoz Canada Incorporated
  • Reata Pharmaceuticals
  • Arena Pharmaceuticals
  • Actelion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Epoprostenol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Epoprostenol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Epoprostenol Market by Type
  6. 1.3.1 Oral Epoprostenol
  7. 1.3.2 Injection Epoprostenol
  8. 1.4 Global Epoprostenol Market Size by Type
  9. 1.4.1 Global Epoprostenol Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Epoprostenol Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Epoprostenol Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Epoprostenol Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Epoprostenol Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Epoprostenol Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Epoprostenol Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Epoprostenol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Epoprostenol Industry Trends
  2. 2.2 Epoprostenol Industry Drivers
  3. 2.3 Epoprostenol Industry Opportunities and Challenges
  4. 2.4 Epoprostenol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Epoprostenol Revenue (2021-2026)
  2. 3.2 Global Top Players by Epoprostenol Sales (2021-2026)
  3. 3.3 Global Top Players by Epoprostenol Price (2021-2026)
  4. 3.4 Global Epoprostenol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Epoprostenol Major Company Production Sites & Headquarters
  6. 3.6 Global Epoprostenol Company, Product Type & Application
  7. 3.7 Global Epoprostenol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Epoprostenol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Epoprostenol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Epoprostenol Tier 1, Tier 2, and Tier 3
4 Epoprostenol Regional Status and Outlook
  1. 4.1 Global Epoprostenol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Epoprostenol Historic Market Size by Region
  3. 4.2.1 Global Epoprostenol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Epoprostenol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Epoprostenol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Epoprostenol Forecasted Market Size by Region
  7. 4.3.1 Global Epoprostenol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Epoprostenol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Epoprostenol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Epoprostenol by Application
  1. 5.1 Epoprostenol Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Epoprostenol Market Size by Application
  6. 5.2.1 Global Epoprostenol Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Epoprostenol Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Epoprostenol Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Epoprostenol Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Epoprostenol Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Epoprostenol Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Epoprostenol Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Epoprostenol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Parenteral
  2. 6.1.1 Teva Parenteral Company Information
  3. 6.1.2 Teva Parenteral Business Overview
  4. 6.1.3 Teva Parenteral Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Parenteral Epoprostenol Product Portfolio
  6. 6.1.5 Teva Parenteral Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Epoprostenol Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Glaxosmithkline Inc
  14. 6.3.1 Glaxosmithkline Inc Company Information
  15. 6.3.2 Glaxosmithkline Inc Business Overview
  16. 6.3.3 Glaxosmithkline Inc Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glaxosmithkline Inc Epoprostenol Product Portfolio
  18. 6.3.5 Glaxosmithkline Inc Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Epoprostenol Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 SteadyMed
  26. 6.5.1 SteadyMed Company Information
  27. 6.5.2 SteadyMed Business Overview
  28. 6.5.3 SteadyMed Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SteadyMed Epoprostenol Product Portfolio
  30. 6.5.5 SteadyMed Recent Developments
  31. 6.6 Sandoz Canada Incorporated
  32. 6.6.1 Sandoz Canada Incorporated Company Information
  33. 6.6.2 Sandoz Canada Incorporated Business Overview
  34. 6.6.3 Sandoz Canada Incorporated Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz Canada Incorporated Epoprostenol Product Portfolio
  36. 6.6.5 Sandoz Canada Incorporated Recent Developments
  37. 6.7 Reata Pharmaceuticals
  38. 6.7.1 Reata Pharmaceuticals Company Information
  39. 6.7.2 Reata Pharmaceuticals Business Overview
  40. 6.7.3 Reata Pharmaceuticals Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Reata Pharmaceuticals Epoprostenol Product Portfolio
  42. 6.7.5 Reata Pharmaceuticals Recent Developments
  43. 6.8 Arena Pharmaceuticals
  44. 6.8.1 Arena Pharmaceuticals Company Information
  45. 6.8.2 Arena Pharmaceuticals Business Overview
  46. 6.8.3 Arena Pharmaceuticals Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Arena Pharmaceuticals Epoprostenol Product Portfolio
  48. 6.8.5 Arena Pharmaceuticals Recent Developments
  49. 6.9 Actelion
  50. 6.9.1 Actelion Company Information
  51. 6.9.2 Actelion Business Overview
  52. 6.9.3 Actelion Epoprostenol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Actelion Epoprostenol Product Portfolio
  54. 6.9.5 Actelion Recent Developments
7 North America by Country
  1. 7.1 North America Epoprostenol Sales by Country
  2. 7.1.1 North America Epoprostenol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Epoprostenol Sales by Country (2021-2026)
  4. 7.1.3 North America Epoprostenol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Epoprostenol Market Size by Country
  6. 7.2.1 North America Epoprostenol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Epoprostenol Market Size by Country (2021-2026)
  8. 7.2.3 North America Epoprostenol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Epoprostenol Sales by Country
  2. 8.1.1 Europe Epoprostenol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Epoprostenol Sales by Country (2021-2026)
  4. 8.1.3 Europe Epoprostenol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Epoprostenol Market Size by Country
  6. 8.2.1 Europe Epoprostenol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Epoprostenol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Epoprostenol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Epoprostenol Sales by Country
  2. 9.1.1 Asia-Pacific Epoprostenol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Epoprostenol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Epoprostenol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Epoprostenol Market Size by Country
  6. 9.2.1 Asia-Pacific Epoprostenol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Epoprostenol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Epoprostenol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Epoprostenol Sales by Country
  2. 10.1.1 South America Epoprostenol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Epoprostenol Sales by Country (2021-2026)
  4. 10.1.3 South America Epoprostenol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Epoprostenol Market Size by Country
  6. 10.2.1 South America Epoprostenol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Epoprostenol Market Size by Country (2021-2026)
  8. 10.2.3 South America Epoprostenol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Epoprostenol Sales by Country
  2. 11.1.1 Middle East and Africa Epoprostenol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Epoprostenol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Epoprostenol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Epoprostenol Market Size by Country
  6. 11.2.1 Middle East and Africa Epoprostenol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Epoprostenol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Epoprostenol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Epoprostenol Value Chain Analysis
  2. 12.1.1 Epoprostenol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Epoprostenol Production Mode & Process
  7. 12.2 Epoprostenol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Epoprostenol Distributors
  10. 12.2.3 Epoprostenol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst